Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Population Genetics Launches Funding Award for Novel Population Sequencing Studies

Published: Monday, October 15, 2012
Last Updated: Monday, October 15, 2012
Bookmark and Share
The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project.

Population Genetics Technologies Ltd. has today launched the Populus Award 2012. Inviting abstracts from researchers undertaking a range of population genetics studies, the award will provide the successful applicant with funding and practical support for their sequencing study, as well as access to the extensive expertise and proprietary technologies provided by Population Genetics. These technologies have the power to increase the efficiency and accuracy of next generation sequencing (NGS) studies, allowing researchers to reliably link genotypic variation with phenotype. Other applicants will also have the chance to benefit from the award, receiving collaborative advice and input from the experts at Population Genetics to help them to further advance their research projects.

Dr. Frank Massam, Chief Commercial Officer, Population Genetics, commented: “The Populus Award 2012 provides an ideal opportunity for a research group with limited funds or experience to gain access to the latest technological and practical expertise in the field. Using our proprietary approaches and funding support, we will enable them to accurately sequence either genomic regions of interest or indeed, whole genes in large populations of samples, providing the next leap in sequencing analysis.”

For the successful applicant, Population Genetics will use its established approach to sequence their samples using the NGS platform of their choice. An innovative molecular tagging system enables the accurate sequencing of either multiple non-contiguous or long, contiguous regions from many thousands of samples, in a single experiment. This allows researchers to confidently identify genetic variants attributed to a specific phenotype. Such high quality data is significantly valuable in areas such as human healthcare, as it mediates the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response, facilitating the development of informed, personalised treatment strategies.

Applications must be submitted online by the 30th of November 2012. The successful applicant will be announced in January 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Population Genetics Collaborates with Cambridge University to Unravel the Genetic Causes of Asperger Syndrome
Joint study aims to identify sequence variants in two genes, both of which have been previously associated with Asperger Syndrome.
Monday, July 09, 2012
Dr Alan Schafer to head Population Genetics as CEO
Schafer brings deep experience in research, “big pharma” management and building new businesses.
Thursday, May 03, 2012
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Gene Deletion Reveals Cell Secrets
Researchers have deleted 174 genes in yeast to analyse the effect of individual gene deletion.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!